"An addition of medium-dose ATG to conditioning regimens favours the long-term survival of patients with allogeneic hematopoietic stem cell transplantation"
written by Anatole A. Klyosov, Igor L. Rozhanskii,
published by Stem Cell Discovery, Vol.3 No.1, 2013
has been cited by the following article(s)：
人类白细胞抗原单倍体相合造血干细胞移植治疗非恶性血液病 13 例临床研究